Mott to host live Q & A on COVID vaccines for kids under 12

Mott experts to answer questions about Pfizer’s COVID vaccine for kids ages 5-11, which FDA advisors approved and could be authorized soon

Author | Beata Mostafavi

University of Michigan Health C.S. Mott Children’s Hospital experts will answer questions about the Pfizer vaccine for children ages 5-11 during a live Q & A session on Friday, Oct. 29.

The live discussion will be held at noon on both the @MottChildren and @MichiganMedicine Facebook pages as well as the @MottChildren and @UMichMedicine Twitter accounts and the Michigan Medicine YouTube channel.

COVID-19 vaccine authorization for younger kids passed a critical step this week after Federal Drug Administration advisors voted in support of the Pfizer vaccine for ages 5-11.

If the vaccine is cleared through the next regulatory steps and is officially authorized, millions of more school-aged kids could qualify for COVID vaccination as early as the first week of November.

“We are getting closer to a major milestone of kids under 12 being eligible for COVID-19 vaccination,” said Luanne Thomas Ewald, FACHE, M.H.A., chief operating officer at Mott and Von Voigtlander Women’s Hospital and who will moderate the live virtual event.

“We know many families are eager to protect their younger children against COVID, but many may also want to learn more as they make this decision for their families. We will host a respectful discussion with our experts who will respond to parents’ top questions and concerns.”

Panelists will include pediatric infectious diseases expert Elizabeth Lloyd, M.D., pediatric cardiologist Jesse Hansen, M.D., and pediatric hospitalist Christine Mikesell, M.D.

Attendees may ask questions live at the time of the event. The video of the chat will also be available afterwards. More information.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Featured News & Stories
News Release
U-M researchers receive Chan Zuckerberg Initiative awards to study neurodegeneration
Six University of Michigan researchers recently received collaborative pair pilot project awards from the Chan Zuckerberg Initiative (CZI) to study neuroscience and neurodegenerative disease.
Animated microscopic image of the glioblastoma's tumor microenvironment
Health Lab
New model of key brain tumor feature could help scientists understand how to develop new treatments
Model shows how oncostreams form and behave in brain tumors – and how to inhibit them
Illustration of scientists and doctors playing basketball in white coats and scrubs
News Release
Four U-M teams selected for virtual tournament of science
U-M researchers' work made the bracket in the 2024 STAT Madness tournament of science, and need public support to advance
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
Older woman checks her face in the mirror
Health Lab
Does trying to look younger reduce how much ageism older adults face?
How do ageism and positive age-related experiences differ for people who have tried to look younger, or feel they look younger, than they actually are? A new study examines this and the relationship with health
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers